Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C May

Showing results (851-860 of 926) with videos related to

Pageof 93
Sort By:
Annals of Neurology|April 11, 2009
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous systemRandall J Bateman, Eric R Siemers, Kwasi G Mawuenyega, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-lifeJohn R Cirrito, Patrick C May, Mark A O'Dell, et al.
Journal of the American Society for Mass Spectrometry|July 23, 2025
Rapid Annotation Strategy for <i>in Vivo</i> Phase II Metabolites of Anabolic-Androgenic Steroids Using Liquid Chromatography-Ion Mobility-Mass SpectrometryDavid C Koomen, Katrina L Leaptrot, Jody C May, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Blood|September 22, 2010
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitorsMustafa Daghistani, David Marin, Jamshid Sorouri Khorashad, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2011
Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studiesD Richard Lachno, Martin J Romeo, Eric R Siemers, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Plos Pathogens|November 4, 2020
Correction: 15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infectionRobert J Evans, Katherine Pline, Catherine A Loynes, et al.
Plos Pathogens|March 29, 2019
15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infectionRobert J Evans, Katherine Pline, Catherine A Loynes, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 30, 2017
Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literatureLauren L Hintenlang, Daniel H Miller, Tasneem Kaleem, et al.
Pageof 93

Showing results (851-860 of 926) with videos related to

Sort By:
Pageof 93
Annals of Neurology|April 11, 2009
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous systemRandall J Bateman, Eric R Siemers, Kwasi G Mawuenyega, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-lifeJohn R Cirrito, Patrick C May, Mark A O'Dell, et al.
Journal of the American Society for Mass Spectrometry|July 23, 2025
Rapid Annotation Strategy for <i>in Vivo</i> Phase II Metabolites of Anabolic-Androgenic Steroids Using Liquid Chromatography-Ion Mobility-Mass SpectrometryDavid C Koomen, Katrina L Leaptrot, Jody C May, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Blood|September 22, 2010
EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitorsMustafa Daghistani, David Marin, Jamshid Sorouri Khorashad, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2011
Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studiesD Richard Lachno, Martin J Romeo, Eric R Siemers, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Plos Pathogens|November 4, 2020
Correction: 15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infectionRobert J Evans, Katherine Pline, Catherine A Loynes, et al.
Plos Pathogens|March 29, 2019
15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infectionRobert J Evans, Katherine Pline, Catherine A Loynes, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 30, 2017
Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literatureLauren L Hintenlang, Daniel H Miller, Tasneem Kaleem, et al.
Pageof 93